GLP-1 receptor agonists induce loss of lean mass: so does caloric restriction

Gabriele Mocciaro¹, Angelo Capodici², Ramona De Amicis^{3

4}

Affiliations

¹ Roger Williams Institute of Liver Studies, Foundation for Liver Research, London, UK.
² Health Science Interdisciplinary Center, Sant'Anna School of Advanced Studies, 56127 Pisa, Italy, Pisa, Italy.
³ IRCCS Istituto Auxologico Italiano, Obesity Unit and Laboratory of Nutrition and Obesity Research, Department of Endocrine and Metabolic Diseases, 20145 Milan, Italy, Milan, Italy.
⁴ International Center for the Assessment of Nutritional Status and the Development of Dietary Intervention Strategies (ICANS-DIS), Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, 20133 Milan, Italy, Milan, Italy.

Editorial

Gabriele Mocciaro et al. BMJ Nutr Prev Health. 2025.

. 2025 Mar 3;8(1):e001206.

doi: 10.1136/bmjnph-2025-001206. eCollection 2025.

Gabriele Mocciaro¹, Angelo Capodici², Ramona De Amicis^{3

4}

¹ Roger Williams Institute of Liver Studies, Foundation for Liver Research, London, UK.
² Health Science Interdisciplinary Center, Sant'Anna School of Advanced Studies, 56127 Pisa, Italy, Pisa, Italy.
³ IRCCS Istituto Auxologico Italiano, Obesity Unit and Laboratory of Nutrition and Obesity Research, Department of Endocrine and Metabolic Diseases, 20145 Milan, Italy, Milan, Italy.
⁴ International Center for the Assessment of Nutritional Status and the Development of Dietary Intervention Strategies (ICANS-DIS), Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, 20133 Milan, Italy, Milan, Italy.

No abstract available

Keywords: Musculo-skeletal health; Nutritional treatment; Weight management.

Conflict of interest statement

No, there are no competing interests.

1. Magkos F, Sørensen TIA, Raubenheimer D, et al. On the pathogenesis of obesity: causal models and missing pieces of the puzzle. Nat Metab. 2024;6:1856–65. doi: 10.1038/s42255-024-01106-8. - DOI - PubMed
1. Taylor R. Understanding the cause of type 2 diabetes. Lancet Diabetes Endocrinol. 2024;12:664–73. doi: 10.1016/S2213-8587(24)00157-8. - DOI - PubMed
1. Holst JJ. GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management. Nat Metab. 2024;6:1866–85. doi: 10.1038/s42255-024-01113-9. - DOI - PubMed
1. Lee WJ, Almalki O. Recent advancements in bariatric/metabolic surgery. Ann Gastroenterol Surg. 2017;1:171–9. doi: 10.1002/ags3.12030. - DOI - PMC - PubMed
1. Pareek M, Schauer PR, Kaplan LM, et al. Metabolic Surgery: Weight Loss, Diabetes, and Beyond. J Am Coll Cardiol. 2018;71:670–87. doi: 10.1016/j.jacc.2017.12.014. - DOI - PubMed